Skip to the page

Data / Form D filings / Reticle Biosystems, Inc.

Reticle Biosystems, Inc.: Form D filing

Reticle Biosystems, Inc., a manufacturing company in San Francisco, CA, filed a Form D with the SEC in 2026. The latest, on July 14, 2026, reports $1 million sold of a $1 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
2261 MARKET STREET STE 78326, San Francisco, CA, 94114
Phone
(415) 881-1831
Industry
Manufacturing
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2026
Revenue range
No Revenues
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2144345

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 14, 2026New notice$1,000,000$1,000,0001Jun 8, 2026sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
James CheExecutive Officer, Director, Promoter

Other manufacturing companies in California that filed recently

Every Form D from the week of Jul 13, 2026 · All recent filings in California · All recent Manufacturing filings

Read from SEC EDGAR. Amount sold is what Reticle Biosystems, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.